Schroder Investment Management Group’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-616,832
| Closed | -$17.6M | – | 1249 |
|
|
2024
Q2 | $17.6M | Buy |
616,832
+11,681
| +2% | +$334K | 0.02% | 502 |
|
|
2024
Q1 | $17.7M | Sell |
605,151
-16,558
| -3% | -$484K | 0.02% | 522 |
|
|
2023
Q4 | $21M | Sell |
621,709
-45,919
| -7% | -$1.55M | 0.03% | 470 |
|
|
2023
Q3 | $20.5M | Sell |
667,628
-171,307
| -20% | -$5.26M | 0.03% | 450 |
|
|
2023
Q2 | $33.6M | Buy |
838,935
+159,258
| +23% | +$6.38M | 0.05% | 361 |
|
|
2023
Q1 | $27.7M | Sell |
679,677
-1,718
| -0.3% | -$70.1K | 0.04% | 403 |
|
|
2022
Q4 | $26.3M | Sell |
681,395
-1,932
| -0.3% | -$74.6K | 0.04% | 394 |
|
|
2022
Q3 | $36.3M | Buy |
683,327
+106,797
| +19% | +$5.68M | 0.06% | 307 |
|
|
2022
Q2 | $33.6M | Sell |
576,530
-119,383
| -17% | -$6.96M | 0.05% | 335 |
|
|
2022
Q1 | $52.7M | Buy |
695,913
+51,751
| +8% | +$3.92M | 0.07% | 278 |
|
|
2021
Q4 | $38.8M | Buy |
644,162
+157,487
| +32% | +$9.48M | 0.05% | 346 |
|
|
2021
Q3 | $27.3M | Sell |
486,675
-73,711
| -13% | -$4.13M | 0.04% | 420 |
|
|
2021
Q2 | $34M | Sell |
560,386
-5,561
| -1% | -$337K | 0.04% | 388 |
|
|
2021
Q1 | $39.7M | Buy |
565,947
+56,617
| +11% | +$3.97M | 0.05% | 345 |
|
|
2020
Q4 | $30.5M | Sell |
509,330
-79,590
| -14% | -$4.76M | 0.04% | 382 |
|
|
2020
Q3 | $35.1M | Sell |
588,920
-90,614
| -13% | -$5.4M | 0.06% | 314 |
|
|
2020
Q2 | $35.7M | Sell |
679,534
-139,634
| -17% | -$7.33M | 0.06% | 293 |
|
|
2020
Q1 | $26.2M | Sell |
819,168
-90,840
| -10% | -$2.91M | 0.06% | 323 |
|
|
2019
Q4 | $41.2M | Buy |
910,008
+118,291
| +15% | +$5.36M | 0.07% | 317 |
|
|
2019
Q3 | $31.7M | Buy |
791,717
+59,244
| +8% | +$2.37M | 0.06% | 358 |
|
|
2019
Q2 | $31.9M | Buy |
732,473
+8,955
| +1% | +$389K | 0.06% | 341 |
|
|
2019
Q1 | $27.5M | Sell |
723,518
-257,617
| -26% | -$9.8M | 0.05% | 393 |
|
|
2018
Q4 | $42.2K | Buy |
981,135
+2,981
| +0.3% | +$128 | 0.08% | 278 |
|
|
2018
Q3 | $48.1M | Sell |
978,154
-276,876
| -22% | -$13.6M | 0.08% | 285 |
|
|
2018
Q2 | $39M | Buy |
1,255,030
+29,223
| +2% | +$907K | 0.07% | 319 |
|
|
2018
Q1 | $38.2M | Buy |
1,225,807
+245,601
| +25% | +$7.65M | 0.07% | 325 |
|
|
2017
Q4 | $44.7M | Buy |
980,206
+32,801
| +3% | +$1.5M | 0.07% | 311 |
|
|
2017
Q3 | $36.7M | Buy |
947,405
+12,237
| +1% | +$474K | 0.06% | 343 |
|
|
2017
Q2 | $45.1M | Buy |
935,168
+6,641
| +0.7% | +$320K | 0.08% | 300 |
|
|
2017
Q1 | $42.6M | Buy |
928,527
+174,505
| +23% | +$8M | 0.08% | 310 |
|
|
2016
Q4 | $24.4M | Buy |
754,022
+90,566
| +14% | +$2.93M | 0.05% | 433 |
|
|
2016
Q3 | $22.7M | Buy |
663,456
+184,256
| +38% | +$6.31M | 0.04% | 446 |
|
|
2016
Q2 | $16.2M | Buy |
+479,200
| New | +$16.2M | 0.03% | 512 |
|